We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




External Cues Can Replace Genetic Manipulation for Cell Reprogramming

By LabMedica International staff writers
Posted on 19 Aug 2008
Cell biologists seeking to transform differentiated adult cells back to cells that resemble embryonic stem cells, have begun the process of replacing virally transmitted genes with environmentally supplied growth factors.

The current state-of-the art is to generate induced pluripotent (IPS) cells by reprogramming adult cells through the use of viruses to transfer four genes (Oct4, Sox2, c-Myc, and Klf4) into the cells' DNA. More...
This process is both inefficient and potentially dangerous in that the retroviruses used for gene transfer are potentially carcinogenic, and c-Myc is a known oncogene whose overexpression can also cause cancer.
In the current study, investigators at the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) left c-Myc out of the formula, replacing it with the protein-signaling molecule Wnt3a. Wnt3a was supplied as an additive to the cells' culture medium rather than as a product of gene transfer.

Results published in the August 6, 2008, online edition of the journal Cell Stem Cell revealed that Wnt3a was able to replace the c-Myc oncogene and, in conjunction with the other three transfected genes, induce the formation of IPS cells.

"IPS cells hold great potential for future medicine, but we must learn how to generate these cells in a manner that is safe for clinical therapies,” said contributing author Dr. Richard Young, professor of biology at MIT. "This advance in reprogramming is one key step toward that goal.”

The investigators concede that while these results mark a good start toward using external cues instead of genetic manipulation to reprogram cells, it is still necessary to eliminate the need for retroviruses for the three other genes.

Related Links:
Massachusetts Institute of Technology



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.